Executive summary: Workshop on Preeclampsia, January 25–26, 2021, cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation

Preeclampsia is a substantial cause of maternal and perinatal morbidity and mortality. The prevalence of this condition has increased over the past several decades.1,2 Additional opportunities are needed to foster interdisciplinary collaborations and improve patient care in the setting of preeclampsia. In recognition of the Preeclampsia Foundation’s 20th anniversary and its work to advance preeclampsia research and clinical agendas, a 2-day workshop on preeclampsia was cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation and held in conjunction with the 41st Annual Pregnancy Meeting. Leaders with expertise in preeclampsia research, obstetrical care, primary care medicine, cardiology, endocrinology, and patient advocacy gathered to discuss preeclampsia prediction, prevention, management, and long-term impacts. The goals of the workshop were to review existing knowledge and create consensus concerning research and clinical priorities:

• To present innovative opportunities for research on predicting, preventing, and managing preeclampsia
• To review benefits and challenges associated with various strategies for prediction, prevention, and management of preeclampsia
• To identify research gaps for the prediction, prevention, and management of preeclampsia
• To discuss needs and opportunities for research, increasing awareness, and risk mitigation of the long-term impacts of preeclampsia

This executive summary briefly reviews the main outcomes of the workshop. A research paper that presents detailed clinical guidance and proposes future research directions will be published at a later date.